NRG Oncology CC001 Neurocognitive Final Analysis: A Phase III Trial of Hippocampal Avoidance (HA) in Addition to Whole‐Brain Radiotherapy (WBRT) Plus Memantine to Preserve Neurocognitive Function (NCF) in Patients With Brain Metastases (BM). (September 2019) - Wefel, Jeffrey S; Pugh, Stephanie; Gondi, Vinai; Brown, Paul D; Tome, Wolfgang; Armstrong, Terri S; Bruner, Deborah; Bovi, Joseph; Robinson, Cliff; Khuntia, Deepak; Grosshans, David; Konski, Andre; et al.